Product Dossier
NARCAN
Product Dossier for NARCAN (naloxone hydrochloride, Phebra). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Phebra
- Active ingredient: naloxone hydrochloride
- Therapeutic area: Pain Management
- Related brand: TARGIN
- Related brand: ARX-Oxycodone/Naloxone
- Related brand: OYONE
- Same area: PALEXIA
- Same area: OXYCONTIN
I cannot write a Brand Dossier for NARCAN based on the documents provided.
The source documents contain: 1. A product information sheet for **TARGIN** (oxycodone/naloxone combination tablets) — not NARCAN 2. ARTG registration records confirming NARCAN is a naloxone injection product 3. PBS listing information for NARCAN injection
However, the detailed product information (indications, dosing, contraindications, safety warnings) needed to populate the Brand Dossier sections comes only from the TARGIN document, which is a different medicine altogether.
To write an accurate Brand Dossier for NARCAN, I would need: — Product information or a consumer medicines information document specific to NARCAN injection — Details of approved indications for NARCAN — Dosing recommendations for NARCAN — Safety warnings and contraindications specific to NARCAN — Regulatory history specific to NARCAN
The current sources do not contain sufficient information about NARCAN itself to support the required Brand Dossier sections with proper citations.